Index by author

August 1, 2024; Volume 65,Issue 8

  1. Abenavoli, Elisabetta Maria

    1. Diverse Imaging Methods May Influence Long-Term Oncologic Outcomes in Oligorecurrent Prostate Cancer Patients Treated with Metastasis-Directed Therapy (the PRECISE-MDT Study)
      Open Access
      Diverse Imaging Methods May Influence Long-Term Oncologic Outcomes in Oligorecurrent Prostate Cancer Patients Treated with Metastasis-Directed Therapy (the PRECISE-MDT Study)
      Matteo Bauckneht, Francesco Lanfranchi, Domenico Albano, Luca Triggiani, Flavia Linguanti, Luca Urso, Rosario Mazzola, Alessio Rizzo, Elisa D’Angelo, Francesco Dondi, Eneida Mataj, Gloria Pedersoli, Elisabetta Maria Abenavoli, Luca Vaggelli, Beatrice Detti, Naima Ortolan, Antonio Malorgio, Alessia Guarneri, Federico Garrou, Matilde Fiorini, Serena Grimaldi, Pietro Ghedini, Giuseppe Carlo Iorio, Antonella Iudicello, Guido Rovera, Giuseppe Fornarini, Diego Bongiovanni, Michela Marcenaro, Filippo Maria Pazienza, Giorgia Timon, Matteo Salgarello, Manuela Racca, Mirco Bartolomei, Stefano Panareo, Umberto Ricardi, Francesco Bertagna, Filippo Alongi, Salvina Barra, Silvia Morbelli, Gianmario Sambuceti and Liliana Belgioia
      Journal of Nuclear Medicine August 1, 2024, 65 (8) 1202-1209; DOI: https://doi.org/10.2967/jnumed.124.267586

  2. Abgral, Ronan

    1. Diagnostic Performance of <sup>18</sup>F-FDG PET/CT According to Delay After Treatment to Detect Subclinical Recurrence of Head and Neck Squamous Cell Carcinoma
      Diagnostic Performance of 18F-FDG PET/CT According to Delay After Treatment to Detect Subclinical Recurrence of Head and Neck Squamous Cell Carcinoma
      Camille Clement, Jean-Christophe Leclère, Clémentine Maheo, Romain Le Pennec, Gregoire Le Gal, Olivier Delcroix, Philippe Robin, Jean Rousset, Valentin Tissot, Aziliz Gueguen, Maryne Allio, Vincent Bourbonne, Ulrike Schick, Remi Marianowski, Pierre-Yves Salaun and Ronan Abgral
      Journal of Nuclear Medicine August 1, 2024, 65 (8) 1181-1187; DOI: https://doi.org/10.2967/jnumed.124.267391

  3. Adilbay, Dauren

    1. Noninvasive Diagnostic Method to Objectively Measure Olfaction and Diagnose Smell Disorders by a Molecularly Targeted Fluorescence Imaging Agent
      Open Access
      Noninvasive Diagnostic Method to Objectively Measure Olfaction and Diagnose Smell Disorders by a Molecularly Targeted Fluorescence Imaging Agent
      Dauren Adilbay, Junior Gonzales, Marianna Zazhytska, Paula Demetrio de Souza Franca, Sheryl Roberts, Tara D. Viray, Raik Artschwager, Snehal Patel, Albana Kodra, Jonathan B. Overdevest, Chun Yuen Chow, Glenn F. King, Sanjay K. Jain, Alvaro A. Ordonez, Laurence S. Carroll, Stavros Lomvardas, Thomas Reiner and Nagavarakishore Pillarsetty
      Journal of Nuclear Medicine August 1, 2024, 65 (8) 1293-1300; DOI: https://doi.org/10.2967/jnumed.123.266123

  4. Ahmadipour, Yahya

    1. The Role of Fibroblast Activation Protein in Glioblastoma and Gliosarcoma: A Comparison of Tissue, <sup>68</sup>Ga-FAPI-46 PET Data, and Survival Data
      The Role of Fibroblast Activation Protein in Glioblastoma and Gliosarcoma: A Comparison of Tissue, 68Ga-FAPI-46 PET Data, and Survival Data
      Christoph Oster, Lukas Kessler, Tobias Blau, Kathy Keyvani, Kim M. Pabst, Wolfgang P. Fendler, Pedro Fragoso Costa, Lazaros Lazaridis, Teresa Schmidt, Jonas Feldheim, Daniela Pierscianek, Hans Ulrich Schildhaus, Ulrich Sure, Yahya Ahmadipour, Christoph Kleinschnitz, Nika Guberina, Martin Stuschke, Cornelius Deuschl, Björn Scheffler, Ken Herrmann, Sied Kebir and Martin Glas
      Journal of Nuclear Medicine August 1, 2024, 65 (8) 1217-1223; DOI: https://doi.org/10.2967/jnumed.123.267151

  5. Aigner, Clemens

    1. Fibroblast Activation Protein–Directed Imaging Outperforms <sup>18</sup>F-FDG PET/CT in Malignant Mesothelioma: A Prospective, Single-Center, Observational Trial
      Fibroblast Activation Protein–Directed Imaging Outperforms 18F-FDG PET/CT in Malignant Mesothelioma: A Prospective, Single-Center, Observational Trial
      Lukas Kessler, Felix Schwaning, Martin Metzenmacher, Kim Pabst, Jens Siveke, Marija Trajkovic-Arsic, Benedikt Schaarschmidt, Marcel Wiesweg, Clemens Aigner, Till Plönes, Kaid Darwiche, Servet Bölükbas, Martin Stuschke, Lale Umutlu, Michael Nader, Dirk Theegarten, Rainer Hamacher, Wilfried E.E. Eberhardt, Martin Schuler, Ken Herrmann, Wolfgang P. Fendler and Hubertus Hautzel
      Journal of Nuclear Medicine August 1, 2024, 65 (8) 1188-1193; DOI: https://doi.org/10.2967/jnumed.124.267473

  6. Albano, Domenico

    1. Diverse Imaging Methods May Influence Long-Term Oncologic Outcomes in Oligorecurrent Prostate Cancer Patients Treated with Metastasis-Directed Therapy (the PRECISE-MDT Study)
      Open Access
      Diverse Imaging Methods May Influence Long-Term Oncologic Outcomes in Oligorecurrent Prostate Cancer Patients Treated with Metastasis-Directed Therapy (the PRECISE-MDT Study)
      Matteo Bauckneht, Francesco Lanfranchi, Domenico Albano, Luca Triggiani, Flavia Linguanti, Luca Urso, Rosario Mazzola, Alessio Rizzo, Elisa D’Angelo, Francesco Dondi, Eneida Mataj, Gloria Pedersoli, Elisabetta Maria Abenavoli, Luca Vaggelli, Beatrice Detti, Naima Ortolan, Antonio Malorgio, Alessia Guarneri, Federico Garrou, Matilde Fiorini, Serena Grimaldi, Pietro Ghedini, Giuseppe Carlo Iorio, Antonella Iudicello, Guido Rovera, Giuseppe Fornarini, Diego Bongiovanni, Michela Marcenaro, Filippo Maria Pazienza, Giorgia Timon, Matteo Salgarello, Manuela Racca, Mirco Bartolomei, Stefano Panareo, Umberto Ricardi, Francesco Bertagna, Filippo Alongi, Salvina Barra, Silvia Morbelli, Gianmario Sambuceti and Liliana Belgioia
      Journal of Nuclear Medicine August 1, 2024, 65 (8) 1202-1209; DOI: https://doi.org/10.2967/jnumed.124.267586

  7. Alipour, Ramin

    1. Clinical Trial Protocol for VIOLET: A Single-Center, Phase I/II Trial Evaluation of Radioligand Treatment in Patients with Metastatic Castration-Resistant Prostate Cancer with [<sup>161</sup>Tb]Tb-PSMA-I&amp;T
      Clinical Trial Protocol for VIOLET: A Single-Center, Phase I/II Trial Evaluation of Radioligand Treatment in Patients with Metastatic Castration-Resistant Prostate Cancer with [161Tb]Tb-PSMA-I&T
      James P. Buteau, Louise Kostos, Ramin Alipour, Price Jackson, Lachlan McInstosh, Brittany Emmerson, Mohammad B. Haskali, Jing Xie, Elizabeth Medhurst, Rajeev Ravi, Brian D. Gonzalez, Heidi Fettke, Benjamin Blyth, Luc Furic, Katie Owen, Shahneen Sandhu, Declan G. Murphy, Arun A. Azad and Michael S. Hofman
      Journal of Nuclear Medicine August 1, 2024, 65 (8) 1231-1238; DOI: https://doi.org/10.2967/jnumed.124.267650

  8. Allio, Maryne

    1. Diagnostic Performance of <sup>18</sup>F-FDG PET/CT According to Delay After Treatment to Detect Subclinical Recurrence of Head and Neck Squamous Cell Carcinoma
      Diagnostic Performance of 18F-FDG PET/CT According to Delay After Treatment to Detect Subclinical Recurrence of Head and Neck Squamous Cell Carcinoma
      Camille Clement, Jean-Christophe Leclère, Clémentine Maheo, Romain Le Pennec, Gregoire Le Gal, Olivier Delcroix, Philippe Robin, Jean Rousset, Valentin Tissot, Aziliz Gueguen, Maryne Allio, Vincent Bourbonne, Ulrike Schick, Remi Marianowski, Pierre-Yves Salaun and Ronan Abgral
      Journal of Nuclear Medicine August 1, 2024, 65 (8) 1181-1187; DOI: https://doi.org/10.2967/jnumed.124.267391

  9. Alongi, Filippo

    1. Diverse Imaging Methods May Influence Long-Term Oncologic Outcomes in Oligorecurrent Prostate Cancer Patients Treated with Metastasis-Directed Therapy (the PRECISE-MDT Study)
      Open Access
      Diverse Imaging Methods May Influence Long-Term Oncologic Outcomes in Oligorecurrent Prostate Cancer Patients Treated with Metastasis-Directed Therapy (the PRECISE-MDT Study)
      Matteo Bauckneht, Francesco Lanfranchi, Domenico Albano, Luca Triggiani, Flavia Linguanti, Luca Urso, Rosario Mazzola, Alessio Rizzo, Elisa D’Angelo, Francesco Dondi, Eneida Mataj, Gloria Pedersoli, Elisabetta Maria Abenavoli, Luca Vaggelli, Beatrice Detti, Naima Ortolan, Antonio Malorgio, Alessia Guarneri, Federico Garrou, Matilde Fiorini, Serena Grimaldi, Pietro Ghedini, Giuseppe Carlo Iorio, Antonella Iudicello, Guido Rovera, Giuseppe Fornarini, Diego Bongiovanni, Michela Marcenaro, Filippo Maria Pazienza, Giorgia Timon, Matteo Salgarello, Manuela Racca, Mirco Bartolomei, Stefano Panareo, Umberto Ricardi, Francesco Bertagna, Filippo Alongi, Salvina Barra, Silvia Morbelli, Gianmario Sambuceti and Liliana Belgioia
      Journal of Nuclear Medicine August 1, 2024, 65 (8) 1202-1209; DOI: https://doi.org/10.2967/jnumed.124.267586

  10. Aluicio-sarduy, Eduardo

    1. Synthesis of <sup>64</sup>Cu-, <sup>55</sup>Co-, and <sup>68</sup>Ga-Labeled Radiopharmaceuticals Targeting Neurotensin Receptor-1 for Theranostics: Adjusting In Vivo Distribution Using Multiamine Macrocycles
      Synthesis of 64Cu-, 55Co-, and 68Ga-Labeled Radiopharmaceuticals Targeting Neurotensin Receptor-1 for Theranostics: Adjusting In Vivo Distribution Using Multiamine Macrocycles
      German O. Fonseca Cabrera, Xinrui Ma, Wilson Lin, Tao Zhang, Weiling Zhao, Liqin Pan, Xiaomei Li, Todd E. Barnhart, Eduardo Aluicio-Sarduy, Huaifu Deng, Xuedan Wu, Kadalipura P. Rakesh, Zibo Li, Jonathan W. Engle and Zhanhong Wu
      Journal of Nuclear Medicine August 1, 2024, 65 (8) 1250-1256; DOI: https://doi.org/10.2967/jnumed.124.267469
« Previous (Pages : 1 2 3 4 5 6 ... 36) Next »
Back to top

In this issue